Sector Update: Healthcare Stocks Steady Pre-Bell Monday
MT newswire2026/10/05 13:2309:23 AM EDT, 10/05/2026 (MT Newswires) -- Healthcare stocks were steady pre-bell Monday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) marginally lower. Vaxcyte (PCVX) shares were up more than 56% after the company said its experimental VAX-31 drug candidate met all pre-specified primary endpoints across age groups studied, compared with Prevnar 20 and/or Capvaxive, in a phase 3 trial of the invasive pneumococcal disease and pneumococcal pneumonia treatment. Alvotech (ALVO) has received US Food and Drug Administration approval for a supplement to the biologics license application for AVT02, marketed as Simlandi in the US, the company said. Alvotech stock was nearly 9% higher premarket. Insmed (INSM) Chief Financial Officer Sara Bonstein is stepping down, the company said. Insmed shares were down more than 2% pre-bell.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Arbitrage trading is still profitable, but the "easy win" era may be over! Citi warns of narrowing spread risks
The US foreign exchange trading team at Citigroup expects that although carry trade strategies may find it difficult to replicate the impressive returns of the previous period, they will still continue to offer profit opportunities for investors.
BNB falls below $700

Continue fueling AI expenses! Oracle (ORCL.US) reportedly close to selling $10 billions in stocks at an 11% discount, priced at $116.
It is reported that Oracle is about to sell shares worth 10 billions USD at an 11% discount.
Synthetix Protocol DAO transfers 428,000 stolen SNX
